1. Lung Cancer. 2018 Feb;116:96-98. doi: 10.1016/j.lungcan.2017.10.013. Epub 2017
 Nov 8.

A patient with malignant pleural mesothelioma carrying BRAF V600E mutation 
responding to vemurafenib.

Chen Y(1), Chen B(2), Zhu X(1), Zhong J(1).

Author information:
(1)Departments of Oncology, Zhuji People's Hospital, Zhuji, Zhejiang Province, 
People's Republic of China; Departments of Radiology, Zhuji People's Hospital, 
Zhuji, Zhejiang Province, People's Republic of China.
(2)Departments of Oncology, Zhuji People's Hospital, Zhuji, Zhejiang Province, 
People's Republic of China; Departments of Radiology, Zhuji People's Hospital, 
Zhuji, Zhejiang Province, People's Republic of China. Electronic address: 
13706855699@139.com.

DOI: 10.1016/j.lungcan.2017.10.013
PMID: 29146159 [Indexed for MEDLINE]